SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-211310
Filing Date
2021-07-09
Accepted
2021-07-09 07:59:55
Documents
14
Period of Report
2021-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d187958d8k.htm   iXBRL 8-K 25129
2 EX-99.1 d187958dex991.htm EX-99.1 22697
6 GRAPHIC g187958r1.jpg GRAPHIC 10672
  Complete submission text file 0001193125-21-211310.txt   193931

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA galt-20210709.xsd EX-101.SCH 2914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20210709_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20210709_pre.xml EX-101.PRE 11422
7 EXTRACTED XBRL INSTANCE DOCUMENT d187958d8k_htm.xml XML 3470
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 211081679
SIC: 2834 Pharmaceutical Preparations